Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

A Case of Bipolar Depression: You Be the Judge

neuroscienceCME Webcast

Premiere Date: Monday, January 25, 2016

This activity offers CE credit for:

1. Physicians (CME)
2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Wednesday, January 25, 2017
Note: Credit Is No Longer Available

Faculty

Charles B. Nemeroff, MD, PhD  Professor and Chair Department of Psychiatry Mulva Clinic for the Neurosciences Director, Institute of Early Life Adversity Research Dell Medical School The University of Texas at Austin Austin, TX

Joseph R. Calabrese, MD  Bipolar Disorders Research Chair and Professor of Psychiatry Case Western Reserve University School of Medicine Director, Mood Disorders Program University Hospitals Case Medical Center Cleveland, OH

Mark A. Frye, MD  Professor and Chair, Department of Psychiatry and Psychology Stephen & Shelly Jackson Family Professorship in Individualized Medicine Director, Mayo Clinic Depression Center Mayo Clinic Rochester, MN

Statement of Need

This video is a replay of a plenary session from the 8th Annual Chair Summit Master Class for Neuroscience Professional Development held in Miami Florida on September 24-26, 2015.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Determine one action you can make to start the conversation about mental illness in your patients and your community.

Financial Support

This activity is supported by CME Outfitters, LLC.

Target Audience

Physicians, physician assistants, nurse practitioners, and other nonphysician health care professionals with an interest in psychiatry, neurology, and the neurosciences.

Credit Information

CME Credit (Physicians):
CME Credit (Physicians): CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.



 CME Outfitters designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST20088 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Nemeroff has the following disclosures:

Research/Grants: National Institutes of Health (NIH)
Consultant: Clintara; Gerson Lehrman Group, Inc. (GLG) Healthcare & Biomedical Council; Lundbeck; Mitsubishi Tanabe Pharma Development America; Prismic Pharmaceuticals, Inc.; Taisho Pharmaceutical Inc.; Takeda Pharmaceuticals North America, Inc.; Total Pain Solutions (TPS); Xhale, Inc. Stockholder: AbbVie Inc.; Celgene Corporation; CeNeRx Biopharm; NovaDel Pharma, Inc.; PharmaNeuroBoost; Revaax Pharmaceuticals LLC; Seattle Genetics, Inc.; Xhale, Inc.
Income Sources or Equity of $10,000 or More: American Psychiatric Publishing; Takeda Pharmaceuticals North America, Inc.; Xhale, Inc.
Patents: Method and devices for transdermal delivery of lithium (US 6,375,990B1); Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2) Scientific Advisory Board: American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (ADAA); Brain & Behavior Research Foundation (BBRF) (formerly National Alliance for Research on Schizophrenia and Depression [NARSAD]); Clintara; RiverMend Health, LLC; Skyland Trail; Xhale, Inc. Board of Directors: American Foundation for Suicide Prevention (AFSP); Anxiety Disorders Association of America (ADAA); Gratitude America.

Dr. Calabrese has the following disclosures:

Research/Grants: AbbVie; AstraZeneca; Cephalon, Inc.; Cleveland Foundation; Eli Lilly and Company; GlaxoSmithKline; Lundbeck; NARSAD; Stanley Medical Research Institute
Consultant: Biomedical Development Corporation; Convergent Health Solutions, LLC; Dainippon Sumitomo Pharma Co., Ltd.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Health & Wellness Partners; Hoffmann-La Roche, Inc.; Lundbeck; Otsuka America Pharmaceutical, Inc.; Pfizer Inc.; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals USA, Inc.; Web ID CME Lectures Supported By: AstraZeneca; Benecke; CME Outfitters, LLC; Dainippon Sumitomo Pharma Co., Ltd.; Elan Pharmaceuticals, Inc.; Forest Laboratories, Inc.; GlasxoSmithKline; Health & Wellness Partners: Lundbeck; Medwiz Healthcare; Otsuka America Pharmaceutical, Inc.; ProMedica; Spirant Communication Pvt. Ltd.; Scientia Ltd; Sunovion Pharmaceuticals Inc.; Takeda Pharmaceuticals USA, Inc.; Teva Pharmaceuticals
Federal Funding: Department of Defense; Health Resources and Services Administration; National Institute of Mental Health

Dr. Frye has the following disclosures:

Research/Grants: AssureRX Health Inc.; Janssen Research & Development, LLC; Mayo Foundation for Medical Education and Research; Myriad Genetics; National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Mental Health (NIMH); Pfizer Inc.
Consultant: Janssen Research & Development, LLC; Mitsubishi Tanabe Pharma Corporation; Myriad Genetics; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals USA
CME/Travel Support: American Physician Institute; CME Outfitters, LLC Other Financial Interest: Mayo Clinic 2015 ? Mayo Clinic has a financial interest in AssureRX and the technology referenced in this publication/presentation

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose



Howard Bliwise, MD (peer reviewer) has no disclosures to report.



Robert Kennedy (planning committee) has no disclosures to report. 



Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).